Search

everythinglearnresearchcommunity

for

Search:↓

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

JAK inhibitors show promise in treating difficult skin diseases.

Erlotinib can cause nonscarring hair loss and itchy skin.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Nilotinib can cause generalized keratosis pilaris.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.